Enhancing siRNA effects in T cells for adoptive immunotherapy

Hematology

Volumn 10, Issue 6, 2005, Pages 461-467

  Morris, Kevin ^a   Castanotto, Daniela ^a   Al Kadhimi, Zaid ^a   Jensen, Michael ^a   Rossi, John ^a   Cooper, Laurence J N ^a,b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Immunotherapy; RNA interference; siRNA; T cells

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; CELLULAR IMMUNITY; DNA MODIFICATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; T LYMPHOCYTE;

EID: 31144463930     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500233569     Document Type: Review

References (108)

1. Dembic, Z and Haas, W and Weiss, S and McCubrey, J and Kiefer, H and von Boehmer, H and Steinmetz, M. (1986) Transfer of specificity by murine alpha and beta T-cell receptor genes Nature, 320, pp. 232-238.
2. Orentas, RJ and Roskopf, SJ and Nolan, GP and Nishimura, MI. (2001) Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide Clin Immunol, 98, pp. 220-228.
3. Geiger, TL and Leitenberg, D and Flavell, RA. (1999) The TCR zeta-chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes J Immunol, 162, pp. 5931-5939.
4. Eshhar, Z and Waks, T and Gross, G and Schindler, DG. (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors Proc Natl Acad Sci USA, 90, pp. 720-724.
5. Romeo, C and Seed, B. (1991) Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides Cell, 64, pp. 1037-1046.
6. Mitsuyasu, RT and Anton, PA and Deeks, SG and Scadden, DT and Connick, E and Downs, MT and Bakker, A and Roberts, MR and June, CH and Jalali, S and (2000) Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects Blood, 96, pp. 785-793.
7. Altenschmidt, U and Klundt, E and Groner, B. (1997) Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression J Immunol, 159, pp. 5509-5515.
8. Cooper, LJ and Kalos, M and Lewinsohn, DA and Riddell, SR and Greenberg, PD. (2000) Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes J Virol, 74, pp. 8207-8212.
9. Kahlon, KS and Brown, C and Cooper, LJ and Raubitschek, A and Forman, SJ and Jensen, MC. (2004) Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells Cancer Res, 64, pp. 9160-9166.
10. Jensen, MC and Cooper, LJ and Wu, AM and Forman, SJ and Raubitschek, A. (2003) Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy Cytotherapy, 5, pp. 131-138.
11. Cooper, LJ and Topp, MS and Serrano, LM and Gonzalez, S and Chang, WC and Naranjo, A and Wright, C and Popplewell, L and Raubitschek, A and Forman, SJ and (2003) T-cell clones can be rendered specific for CD19: Toward the selective augmentation of the graft-versus-B-lineage leukemia effect Blood, 10, pp. 1637-1644.
12. Dilloo, D and Bacon, K and Holden, W and Zhong, W and Burdach, S and Zlotnik, A and Brenner, M. (1996) Combined chemokine and cytokine gene transfer enhances antitumor immunity Nat Med, 2, pp. 1090-1095.
13. Hwu, P and Yannelli, J and Kriegler, M and Anderson, WF and Perez, C and Chiang, Y and Schwarz, S and Cowherd, R and Delgado, C and Mule, J and (1993) Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans J Immunol, 150, pp. 4104-4115.
14. Wagner, HJ and Bollard, CM and Vigouroux, S and Huls, MH and Anderson, R and Prentice, HG and Brenner, MK and Heslop, HE and Rooney, CM. (2004) A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells Cancer Gene Ther, 11, pp. 81-91.
15. Kershaw, MH and Jackson, JT and Haynes, NM and Teng, MW and Moeller, M and Hayakawa, Y and Street, SE and Cameron, R and Tanner, JE and Trapani, JA and (2004) Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer J Immunol, 173, pp. 2143-2150.
16. Rooney, CM and Smith, CA and Ng, CY and Loftin, SK and Sixbey, JW and Gan, Y and Srivastava, DK and Bowman, LC and Krance, RA and Brenner, MK and (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood, 92, pp. 1549-1555.
17. Chouaib, S and Asselin-Paturel, C and Mami-Chouaib, F and Caignard, A and Blay, JY. (1997) The host-tumor immune conflict: From immunosuppression to resistance and destruction Immunol Today, 18, pp. 493-497.
18. Wahl, SM and McCartney-Francis, N and Mergenhagen, SE. (1989) Inflammatory and immunomodulatory roles of TGF-beta Immunol Today, 10, pp. 258-261.
19. Ruegemer, JJ and Ho, SN and Augustine, JA and Schlager, JW and Bell, MP and McKean, DJ and Abraham, RT. (1990) Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression J Immunol, 144, pp. 1767-1776.
20. Palladino, MA and Morris, RE and Starnes, HF and Levinson, AD. (1990) The transforming growth factor-betas. A new family of immunoregulatory molecules Ann NY Acad Sci, 593, pp. 181-187.
21. Bollard, CM and Rossig, C and Calonge, MJ and Huls, MH and Wagner, HJ and Massague, J and Brenner, MK and Heslop, HE and Rooney, CM. (2002) Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity Blood, 99, pp. 3179-3187.
22. Montgomery MK, Xu S Fire A. (1998) RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans Proc Natl Acad Sci, 95, 15502 - 15507.
23. Nishikura, K. (2001) A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst Cell, 107, pp. 415 - 418.
24. Sharp, PA. (2001) RNA interference Genes Dev, 15, pp. 485 - 490.
25. Pal-Bhadra, M and Leibovitch, BA and Gandhi, SG and Rao, M and Bhadra, U and Birchler, JA and Elgin, SC. (2004) Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery Science, 303, pp. 669 - 672.
26. Sijen, T and Vijn, I and Rebocho, A and van Blokland, R and Roelofs, D and Mol, JN and Kooter, JM. (2001) Transcriptional and posttranscriptional gene silencing are mechanistically related Curr Biol, 11, pp. 436 - 440.
27. Bosher, JM and Dugourcq, P and Sookhareea, S and Labouesse, M. (1999) RNA interference can target pre-mRNA: Consequences for gene expression in a caenorhabditis elegans operon Genetics, 153, pp. 1245 - 1256.
28. Ramaswamy, SlackFJ. (2002) siRNA. A guide for RNA silencing Chem Biol, 9, pp. 1053 - 1055.
29. Wassenegger, M and Graham, MW and Wang, MD. (1994) RNA-directed de novo methylation of genomic sequences in plants Cell, 76, pp. 567 - 576.
30. Wassenegger, M. (2000) RNA-directed DNA methylation Plant Mol Biol, 43, pp. 203 - 220.
31. Zeng, Y and Cullen, BR. (2002) RNA interference in human cells is restricted to the cytoplasm RNA, 8, pp. 855 - 860.
32. Fire, A and Xu, S and Montgomery, MK and Kostas, SA and Driver, SE and Mello, CC. (1998) Potent and specific genetic interference by double stranded RNA in caenorhabditis elegans Nature, 391, pp. 806 - 811.
33. Montgomery, MK and Xu, S and Fire, A. (1998) RNA as a target of double-stranded RNA-mediated genetic interference in caenorhabditis elegans Proc Natl Acad Sci USA, 95, pp. 15502 - 15507.
34. Ngo, H and Tschudi, C and Gull, K and Ullu, E. (1998) Double-stranded RNA induces mRNA degradation in Trypanosoma brucei Proc Natl Acad Sci USA, 95, pp. 14687 - 14692.
35. Morris, KV and Chan, SW and Jacobsen, SE and Looney, DJ. (2004) Small interfering RNA-induced transcriptional gene silencing in human cells Science, 305, pp. 1289 - 1292.
36. Kawasaki, H and Taira, K. (2004) Induction of DNA methylation and gene silencing by short interfering RNAs in human cells Nature, 431, pp. 211 - 217.
37. Elbashir, SM and Harborth, J and Lendeckel, W and Yalcin, A and Weber, K and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature, 411, pp. 494 - 498.
38. Boese, Q and Leake, D and Reynolds, A and Read, S and Scaringe, SA and Marshall, WS and Khvorova, A. (2005) Mechanistic insights aid computational short interfering RNA design Methods Enzymol, 392, pp. 73 - 96.
39. Watt, TJ and Doyle, DF. (2005) ESPSearch: A program for finding exact sequences and patterns in DNA, RNA or protein Biotechniques, 38, pp. 109 - 115.
40. Reynolds, A and Leake, D and Boese, Q and Scaringe, S and Marshall, WS and Khvorova, A. (2004) Rational siRNA design for RNA interference Nat Biotechnol, 22, pp. 326 - 330.
41. Hernandez-Hoyos, G and Alberola-Ila, J. (2005) Analysis of T-cell development by using short interfering RNA to knock down protein expression Methods Enzymol, 392, pp. 199 - 217.
42. Lovett-Racke, AE and Rocchini, AE and Choy, J and Northrop, SC and Hussain, RZ and Ratts, RB and Sikder, D and Racke, MK. (2004) Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes Immunity, 21, pp. 719 - 731.
43. Skapenko, A and Leipe, J and Niesner, U and Devriendt, K and Beetz, R and Radbruch, A and Kalden, JR and Lipsky, PE and Schulze-Koops, H. (2004) GATA-3 in human T cell helper type 2 development J Exp Med, 199, pp. 423 - 428.
44. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N, (2002) ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum Nature, 419, 480 - 483.
45. Vang, T and Abrahamsen, H and Myklebust, S and Enserink, J and Prydz, H and Mustelin, T and Amarzguioui, M and Tasken, K. (2004) Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells Eur J Immunol, 34, pp. 2191 - 2199.
46. Vang, T and Abrahamsen, H and Myklebust, S and Enserink, J and Prydz, H and Mustelin, T and Amarzguioui, M and Tasken, K. (2004) Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells Eur J Immunol, 34, pp. 2191 - 2199.
47. Radu, CG and Yang, LV and Riedinger, M and Au, M and Witte, ON. (2004) T cell chemotaxis to lysophosphatidylcholine through the G2A receptor Proc Natl Acad Sci USA, 101, pp. 245 - 250.
48. McManus MT, Haines BB, Dillon CP, Whitehurst CE, van Parijs L, Chen J, Sharp PA. (2002) Small interfering RNA-mediated gene silencing in T lymphocytes J Immunol, 169, 5754-5760.
49. Samten, B and Howard, ST and Weis, SE and Wu, S and Shams, H and Townsend, JC and Safi, H and Barnes, PF and Cyclic, AMP. (2005) Response element-binding protein positively regulates production of IFN-{gamma} by T cells in response to a microbial pathogen J Immunol, 174, pp. 6357 - 6363.
50. Migliaccio, M and Raj, K and Menzel, O and Rufer, N. (2005) Mechanisms that limit the in vitro proliferative potential of human CD8+T lymphocytes J Immunol, 174, pp. 3335 - 3343.
51. Gomez, TS and Hamann, MJ and McCarney, S and Savoy, DN and Lubking, CM and Heldebrant, MP and Labno, CM and McKean, DJ and McNiven, MA and Burkhardt, JK and (2005) Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse Nat Immunol, 6, pp. 261 - 270.
52. Hsieh, AC and Bo, R and Manola, J and Vazquez, F and Bare, O and Khvorova, A and Scaringe, S and Sellers, WR. (2004) A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: Determinants of gene silencing for use in cell-based screens Nucleic Acids Res, 32, pp. 893 - 901.
53. Luo, B and Heard, AD and Lodish, HF. (2004) Small interfering RNA production by enzymatic engineering of DNA (SPEED) Proc Natl Acad Sci USA, 101, pp. 5494 - 5499.
54. Brazas, RM and Hagstrom, JE. (2005) Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents Methods Enzymol, 392, pp. 112 - 124.
55. Spagnou, S and Miller, AD and Keller, M. (2004) Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA Biochemistry, 43, pp. 13348 - 13356.
56. Dalby, B and Cates, S and Harris, A and Ohki, EC and Tilkins, ML and Price, PJ and Ciccarone, VC. (2004) Advanced transfection with Lipofectamine 2000 reagent: Primary neurons, siRNA, and high-throughput applications Methods, 33, pp. 95 - 103.
57. Gresch, O and Engel, FB and Nesic, D and Tran, TT and England, HM and Hickman, ES and Korner, I and Gan, L and Chen, S and Castro-Obregon, S and (2004) New non-viral method for gene transfer into primary cells Methods, 33, pp. 151 - 163.
58. Persengiev, SP and Zhu, X and Green, MR. (2004) Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs) RNA, 10, pp. 12 - 18.
59. Pebernard, S and Iggo, RD. (2004) Determinants of interferon-stimulated gene induction by RNAi vectors Differentiation, 72(2-3), pp. 103 - 111.
60. Sledz, CA and Holko, M and de Veer, MJ and Silverman, RH and Williams, BR. (2003) Activation of the interferon system by short-interfering RNAs Nat Cell Biol, 5, pp. 834 - 839.
61. Banerjea, A and Li, MJ and et al. (2003) Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages Mol Ther, 8, pp. 62 - 71.
62. Izsvak, Z and Ivics, Z and Plasterk, RH. (2000) Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates J Mol Biol, 302, pp. 93 - 102.
63. Wu, X and Li, Y and Crise, B and Burgess, SM. (2003) Transcription start regions in the human genome are favored targets for MLV integration Science, 300, pp. 1749 - 1751.
64. Buchschacher, GL and Wong-Staal, F. (2000) Development of lentiviral vectors for gene therapy for human diseases Blood, 95, pp. 2499 - 2504.
65. Freed, EO and Martin, MA. (1994) HIV-1 infection of non-dividing cells Nature, 369, pp. 107 - 108.
66. Greber, U. (2003) Fassati a nuclear import of viral DNA genomes Traffic, 4, pp. 136 - 143.
67. Gervaix, A and Schwarz, L and Law, P and Ho, AD and Looney, D and Wong-Staal, F. (1997) Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals Human Gene Ther, 8, pp. 2229 - 2238.
68. Poeschla, E and Corbeau, P and Wong-Staal, F. (1996) Development of HIV vectors for anti-HIV gene therapy Proc Natl Acad Sci USA, 93, pp. 11395 - 11399.
69. Price, MA and Case, SS and Carbonaro, DA and Yu, XJ and Petersen, D and Sabo, KM and Curran, MA and Engel, BC and Margarian, H and Abkowitz, JL and (2002) Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells Mol Ther, 6, pp. 645 - 652.
70. Quinonez, R and Sutton, RE. (2002) Lentiviral vectors for gene delivery into cells DNA Cell Biol, 12, pp. 937 - 951.
71. Yam, PY and Li, S and Wu, JU and Hu, J and Zaia, JA and Yee, J. (2002) Design of HIV vectors for efficient gene delivery into human hematopoietic cells Mol Ther, 5, pp. 479 - 484.
72. Browning, MT and Schmidt, RD and Lew, KA and Rizvi, TA. (2001) Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions J Virol, 75, pp. 5129 - 5140.
73. Goujon, C and Jarrosson-Wuilleme, L and Bernaud, J and Rigal, D and Darlix, JL and Cimarelli, A. (2003) Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells J Virol, 77, pp. 9295 - 9304.
74. White, SM and Renda, M and Nam, NY and Klimatcheva, E and Zhu, Y and Fisk, J and Halterman, M and Rimel, BJ and Federoff, H and Pandya, S and (1999) Lentivirus vectors using human and simian immunodeficiency virus elements J Virol, 73, pp. 2832 - 2840.
75. Morris, KV and Chan, SW and Jacobsen, SE and Looney, DJ. (2004) Small interfering RNA-induced transcriptional gene silencing in human cells Science, 305, pp. 1289 - 1292.
76. Izsvak, Z and Ivics, Z and Plasterk, RH. (2000) Sleeping deauty, a wide host-range transposon vector for genetic transformation in vertebrates J Mol Biol, 302, pp. 93 - 102.
77. Plasterk, RH and Izsvak, Z and Ivics, Z. (1999) Resident aliens: The Tc1/ mariner superfamily of transposable elements Trends Genet, 15, pp. 326 - 332.
78. Lee, NS and Dohjima, T and Bauer, G and Li, H and Li, MJ and Ehsani, A and Salvaterra, P and Rossi, J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nat Biotechnol, 20, pp. 500 - 505.
79. Gonzalez, S and Castanotto, D and Li, H and Olivares, S and Jensen, MC and Forman, SJ and Rossi, JJ and Cooper, LJ. (2003) Amplification of RNAi-targeting HLA mRNAs Mol Ther, 11, pp. 811 - 818.
80. Xia, XG and Zhou, H and Ding, H and Affar el, B and Shi, Y and Xu, Z. (2003) An enhanced U6 promoter for synthesis of short hairpin RNA Nucleic Acids Res, 31, pp. e100.
81. Coburn, GA and Cullen, BR. (2002) Potent and specific inhibition of human immunodeficiency virus Type 1 replication by RNA interference J Virol, 76, pp. 9225 - 9231.
82. Lee, NS and Dohjima, T and Bauer, G and Li, H and Li, MJ and Ehsani, A and Salvaterra, P and Rossi, J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nat Biotechnol, 20, pp. 500 - 505.
83. Qin, X and An, D and Chen, ISY and Baltimore, D. (2002) Inhibiting HIV-1 infection in human T cells by lentiviral mediated delivery of small interfering RNA against CCR5 PNAS, 100, pp. 183 - 188.
84. Surabhi, RM and Gaynor, RB. (2002) RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus Type 1 replication J Virol, 76, pp. 12963 - 12973.
85. Morris, KV and Gilbert, J and Wong-Staal, F and Gasmi, M and Looney, DJ. (2004) Transduction of cell lines and primary cells by FIV-packaged HIV vectors Mol Ther, 10, pp. 181 - 190.
86. Novina, CD and Murray, MF and Dykxhoorn, DM and Beresford, PJ and Riess, J and Lee, S and Collman, RG and Leiberman, J and Shankar, P and Sharp, PA. (2002) siRNA-directed inhibtion of HIV-1 infection Nat Med, 8, pp. 681 - 686.
87. Westerhout, EM and Ooms, M and (2005) HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome Nucleic Acids Res, 33, pp. 796 - 804.
88. Chang, LJ and Liu, X and He, J. (2005) Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1 Gene Ther, 3. Mar 3; [Epub ahead of print]
89. Novina, CD and Murray, MF and Dykxhoorn, DM and Beresford, PJ and Riess, J and Lee, SK and Collman, RG and Lieberman, J and Shankar, P and Sharp, PA. (2002) siRNA-directed inhibition of HIV-1 infection Nat Med, 8, pp. 681 - 686.
90. Unwalla, HJ and Li, MJ and Kim, JD and Li, HT and Ehsani, A and Alluin, J and Rossi, JJ. (2004) Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA Nat Biotechnol, 22, pp. 1573 - 1578.
91. Akkina, R and Banerjea, A and Bai, J and Anderson, J and Li, MJ and Rossi, J. (2003) siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS Anticancer Res, 23, pp. 1997 - 2005.
92. Qin, XF and An, DS and Chen, IS and Baltimore, D. (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 Proc Natl Acad Sci USA, 100, pp. 183 - 188.
93. Capodici, J and Kariko, K and Weissman, D. (2002) Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference J Immunol, 169, pp. 5196 - 5201.
94. Butticaz, C and Ciuffi, A and Munoz, M and Thomas, J and Bridge, A and Pebernard, S and Iggo, R and Meylan, P and Telenti, A. (2003) Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression Antivir Ther, 8, pp. 373 - 377.
95. Rose, JJ and Janvier, K and Chandrasekhar, S and Sekaly, RP and Bonifacino, JS and Venkatesan, S. (2005) CD4 down-regulation by HIV-1 and simian immunodeficiency virus (SIV) Nef proteins involves both internalization and intracellular retention mechanisms J Biol Chem, 280, pp. 7413 - 7426.
96. Lee, SK and Dykxhoorn, DM and Kumar, P and Ranjbar, S and Song, E and Maliszewski, LE and Francois-Bongarcon, V and Goldfeld, A and Swamy, MN and Lieberman, J and (2005) Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV Blood, 14. Apr 14; [Epub ahead of print]
97. O'Connell, J and Bennett, MW and O'Sullivan, GC and Collins, JK and Shanahan, F. (1999) Fas counter-attack-the best form of tumor defense? Nat Med, 5, pp. 267 - 268.
98. Cooper, LJ and Al-Kadhimi, Z and DiGiusto, D and Kalos, M and Colcher, D and Raubitschek, A and Forman, SJ and Jensen, MC. (2004) Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies Blood Cells Mol Dis, 33, pp. 83 - 89.
99. Cooper, LJ and Al-Kadhimi, Z and Serrano, LM and Pfeiffer, T and Olivares, S and Castro, A and Chang, WC and Gonzalez, S and Smith, D and Forman, SJ and (2005) Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1 Blood, 105, pp. 1622 - 1631.
100. Jensen, MC and Clarke, P and Tan, G and Wright, C and Chung-Chang, W and Clark, TN and Zhang, F and Slovak, ML and Wu, AM and Forman, SJ and (2000) Human T lymphocyte genetic modification with naked DNA Mol Ther, 1, pp. 49 - 55.
101. Wang, J and Press, OW and Lindgren, CG and Greenberg, P and Riddell, S and Qian, X and Laugen, C and Raubitschek, A and Forman, SJ and Jensen, MC. (2004) Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes Mol Ther, 9, pp. 577 - 586.
102. Gonzalez, S and Naranjo, A and Serrano, LM and Chang, WC and Wright, CL and Jensen, MC. (2004) Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma J Gene Med, 6, pp. 704 - 711.
103. Yano, J and Hirabayashi, K and Nakagawa, S and Yamaguchi, T and Nogawa, M and Kashimori, I and Naito, H and Kitagawa, H and Ishiyama, K and Ohgi, T and (2004) Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer Clin Cancer Res, 10, pp. 7721 - 7726.
104. Zhang, X and Shan, P and Jiang, D and Noble, PW and Abraham, NG and Kappas, A and Lee, PJ. (2004) Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis J Biol Chem, 279, pp. 10677 - 10684.
105. Zender, L and Hutker, S and Liedtke, C and Tillmann, HL and Zender, S and Mundt, B and Waltemathe, M and Gosling, T and Flemming, P and Malek, NP and (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice Proc Natl Acad Sci USA, 100, pp. 7797 - 7802.
106. Urban-Klein, B and Werth, S and Abuharbeid, S and Czubayko, F and Aigner, A. (2004) RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo Gene Ther, 23. Dec 23; [Epub ahead of print]
107. Thakker, DR and Natt, F and Husken, D and Maier, R and Muller, M and van der Putten, H and Hoyer, D and Cryan, JF. (2004) Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference Proc Natl Acad Sci U S A, 101, pp. 17270 - 17275.
108. Xia H, Mao Q, Paulson HL, Davidson BL, siRNA-Medicated gene silencing in vitro and in vivo. Nat Biotechnol 2002;20:1006-1010.